Login to Your Account

Cardio3 BioSciences Grosses $30M in Brussels, Paris IPO

By Cormac Sheridan
Staff Writer

Wednesday, July 10, 2013
Shares in Cardio3 Biosciences SA performed strongly on their first day of trading, following a July 4 initial public offering (IPO) on the NYSE Euronext exchanges in Brussels and Paris that raised €23 million (US$29.6 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription